Your browser doesn't support javascript.
loading
HLA alleles, disease severity, and age associate with T-cell responses following infection with SARS-CoV-2.
Olafsdottir, Thorunn A; Bjarnadottir, Kristbjorg; Norddahl, Gudmundur L; Halldorsson, Gisli H; Melsted, Pall; Gunnarsdottir, Kristbjorg; Ivarsdottir, Erna; Olafsdottir, Thorhildur; Arnthorsson, Asgeir O; Theodors, Fannar; Eythorsson, Elias; Helgason, Dadi; Eggertsson, Hannes P; Masson, Gisli; Bjarnadottir, Sólveig; Saevarsdottir, Saedis; Runolfsdottir, Hrafnhildur L; Olafsson, Isleifur; Saemundsdottir, Jona; Sigurdsson, Martin I; Ingvarsson, Ragnar F; Palsson, Runolfur; Thorgeirsson, Gudmundur; Halldorsson, Bjarni V; Holm, Hilma; Kristjansson, Mar; Sulem, Patrick; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Gudbjartsson, Daniel F; Stefansson, Kari.
Afiliación
  • Olafsdottir TA; deCODE genetics/Amgen Inc., Reykjavik, Iceland. thorunn.olafsdottir@decode.is.
  • Bjarnadottir K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Norddahl GL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Halldorsson GH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Melsted P; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gunnarsdottir K; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
  • Ivarsdottir E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Olafsdottir T; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Arnthorsson AO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Theodors F; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Eythorsson E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Helgason D; Internal Medicine and Emergency Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Eggertsson HP; Internal Medicine and Emergency Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Masson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Bjarnadottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Saevarsdottir S; Internal Medicine and Emergency Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Runolfsdottir HL; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Olafsson I; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Saemundsdottir J; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Sigurdsson MI; Department of Medicine, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Ingvarsson RF; Internal Medicine and Emergency Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Palsson R; Clinical Laboratory Services, Diagnostics and Blood Bank, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Thorgeirsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Halldorsson BV; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Holm H; Perioperative Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Kristjansson M; Internal Medicine and Emergency Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Sulem P; Internal Medicine and Emergency Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Thorsteinsdottir U; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Jonsdottir I; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gudbjartsson DF; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Stefansson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Commun Biol ; 5(1): 914, 2022 09 06.
Article en En | MEDLINE | ID: mdl-36068292
Memory T-cell responses following SARS-CoV-2 infection have been extensively investigated but many studies have been small with a limited range of disease severity. Here we analyze SARS-CoV-2 reactive T-cell responses in 768 convalescent SARS-CoV-2-infected (cases) and 500 uninfected (controls) Icelanders. The T-cell responses are stable three to eight months after SARS-CoV-2 infection, irrespective of disease severity and even those with the mildest symptoms induce broad and persistent T-cell responses. Robust CD4+ T-cell responses are detected against all measured proteins (M, N, S and S1) while the N protein induces strongest CD8+ T-cell responses. CD4+ T-cell responses correlate with disease severity, humoral responses and age, whereas CD8+ T-cell responses correlate with age and functional antibodies. Further, CD8+ T-cell responses associate with several class I HLA alleles. Our results, provide new insight into HLA restriction of CD8+ T-cell immunity and other factors contributing to heterogeneity of T-cell responses following SARS-CoV-2 infection.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Commun Biol Año: 2022 Tipo del documento: Article País de afiliación: Islandia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Commun Biol Año: 2022 Tipo del documento: Article País de afiliación: Islandia Pais de publicación: Reino Unido